Updated at 9:50 a.m., April 24, to reflect that Cura has not been listed as an authorized manufacturer on the department’s website.

Cura TeleHealth and Wellness announced last week that drive-through testing for the coronavirus will be available in Allen and Richardson as part of a collaboration between Cura TeleHealth and Post Acute Medical Hospitals.

PAM Hospitals said in a news release that the antibody tests — which involves a small blood collection to detect an immune response to the virus — were authorized by the U.S. Food and Drug Administration.

In mid-March, the FDA loosened its guidelines and allowed companies to sell antibody tests without prior FDA review. However, the department has since clarified that this does not mean all antibody tests receive automatic authorization, after learning companies were falsely claiming their tests had been approved by the FDA.

“Some developers have misused the serology test kit notification list to falsely claim their serological tests are FDA approved or authorized,” the FDA wrote in a release. “Others have falsely claimed that their tests can diagnose COVID-19. When we become aware of these issues, we have and will continue to take appropriate action against firms making or distributing unvalidated tests or those making false claims, such as issuing warning letters requesting that companies stop their unlawful promotion and detaining and refusing fraudulent test kits at the border.”

As of Thursday afternoon, Cura has not been listed as an authorized manufacturer on the department’s website. The company has not responded to a request for comment.

PAM Rehabilitation Hospital in Allen is still listed as a location that offers the testing, but the Richardson location is no longer listed. It was unclear late Thursday if the hospital was still offering it.

The test costs $169 out of pocket, but people are encouraged to show insurance, according to information on Cura’s website.

Cura CEO Clint Baird said in the release that a positive result means the person has been exposed to the virus and the body’s immune system has responded. However, the test does not determine whether a person is no longer contagious or is free of the virus. He encouraged everyone to continue practicing guidelines on social distancing and hygiene.

“We look forward to the opportunity to provide space for Cura Telehealth to conduct community COVD-19 testing,” Post Acute Medical CEO Anthony Misitano said in the release. “We are committed to our communities, and PAM wants to do its part to provide onsite space for increased testing in our communities.”